Bacteria-instructed B cells cross-prime naïve CD8+ T cells triggering effective cytotoxic responses

EMBO Rep. 2023 Jul 5;24(7):e56131. doi: 10.15252/embr.202256131. Epub 2023 May 15.

Abstract

In addition to triggering humoral responses, conventional B cells have been described in vitro to cross-present exogenous antigens activating naïve CD8+ T cells. Nevertheless, the way B cells capture these exogenous antigens and the physiological roles of B cell-mediated cross-presentation remain poorly explored. Here, we show that B cells capture bacteria by trans-phagocytosis from previously infected dendritic cells (DC) when they are in close contact. Bacterial encounter "instructs" the B cells to acquire antigen cross-presentation abilities, in a process that involves autophagy. Bacteria-instructed B cells, henceforth referred to as BacB cells, rapidly degrade phagocytosed bacteria, process bacterial antigens and cross-prime naïve CD8+ T cells which differentiate into specific cytotoxic cells that efficiently control bacterial infections. Moreover, a proof-of-concept experiment shows that BacB cells that have captured bacteria expressing tumor antigens could be useful as novel cellular immunotherapies against cancer.

Keywords: Listeria monocytogenes; B cell-mediated antigen cross-presentation; cancer immunotherapy; cellular therapy; transphagocytosis.

MeSH terms

  • Antigen Presentation
  • Antigens, Bacterial
  • CD8-Positive T-Lymphocytes*
  • Cross-Priming
  • Dendritic Cells*

Substances

  • Antigens, Bacterial